BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8222563)

  • 21. Lung cancer in Maharaj Nakorn Chiang Mai Hospital: comparison of the clinical manifestations between the young and old age groups.
    Deesomchok A; Dechayonbancha N; Thongprasert S
    J Med Assoc Thai; 2005 Sep; 88(9):1236-41. PubMed ID: 16536110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping.
    Riquet M; Foucault C; Berna P; Assouad J; Dujon A; Danel C
    Ann Thorac Surg; 2006 Jun; 81(6):1988-95. PubMed ID: 16731118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Postoperative adjuvant therapy for 189 patients with completely resected non-small cell lung cancer of stage III(A)].
    Li Q; Gao JM; Liang PY; Xie FY; Liu GZ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1463-6. PubMed ID: 15566658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical patterns and treatment outcome of elderly patients in clinical stage IB/II non-small cell lung cancer.
    Okamoto T; Maruyama R; Shoji F; Ikeda J; Miyamoto T; Nakamura T; Asoh H; Ichinose Y
    J Surg Oncol; 2004 Sep; 87(3):134-8. PubMed ID: 15334641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical therapy for carcinoma of the lung.
    Shields TW
    Clin Chest Med; 1993 Mar; 14(1):121-47. PubMed ID: 8384959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
    Strauss GM; Lynch TJ; Elias AD; Jacobs C; Herbst R; Leong T; Lynch C; Kwiatkowski DJ; Carey RW; Grossbard ML; Skarin AT
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension.
    Okada M; Sakamoto T; Nishio W; Uchino K; Tsubota N
    Cancer; 2003 Aug; 98(3):535-41. PubMed ID: 12879471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of age on survival of clinical stage I non-small-cell lung cancer.
    Sigel K; Bonomi M; Packer S; Wisnivesky J
    Ann Surg Oncol; 2009 Jul; 16(7):1912-7. PubMed ID: 19408051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10.
    Pepe C; Hasan B; Winton TL; Seymour L; Graham B; Livingston RB; Johnson DH; Rigas JR; Ding K; Shepherd FA;
    J Clin Oncol; 2007 Apr; 25(12):1553-61. PubMed ID: 17442999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Twelve-year follow-up of trimodality therapy for stage IIIA non-small cell lung cancer.
    Weitberg AB; Liu L; Yashar J; Glicksman AS
    J Exp Clin Cancer Res; 2001 Sep; 20(3):335-40. PubMed ID: 11718211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical evaluation of the small-cell and poorly differentiated forms of squamous-cell and glandular lung cancers].
    Pirogov AI; Polotskiĭ BE; Al-Ansari N; Volkov SM; Popesku KF
    Vopr Onkol; 1989; 35(2):154-8. PubMed ID: 2467441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Updates in small cell lung cancer treatment.
    Walker S
    Clin J Oncol Nurs; 2003; 7(5):563-8. PubMed ID: 14603554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on the diagnosis and prognosis of T1 primary cancer in the periphery of the lung].
    Sawada K
    Gan No Rinsho; 1984 Dec; 30(15):1866-70. PubMed ID: 6098745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characteristics of the therapeutic measures in lung cancer].
    Berëzkin DP; Vagner RI; Ekimov VI; Filatov VN
    Vopr Onkol; 1988; 34(8):936-42. PubMed ID: 2458655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lung cancer in the elderly.
    Filderman AE; Shaw C; Matthay RA
    Clin Geriatr Med; 1986 May; 2(2):363-83. PubMed ID: 3516369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [What is safe in the therapy of non-small cell bronchial cancer?].
    Gropp C
    Internist (Berl); 1984 Dec; 25(12):747-51. PubMed ID: 6097563
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diagnosis and treatment of lung cancer in Shanghai--an analysis of present status].
    Liao ML
    Zhonghua Zhong Liu Za Zhi; 1992 May; 14(3):228-30. PubMed ID: 1396066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [An analysis of the therapeutic effects of 120 cases of lung cancer in the elderly].
    Xu YN
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1985 Dec; 8(6):321-4, 372. PubMed ID: 3015519
    [No Abstract]   [Full Text] [Related]  

  • 39. [Analysis of patients registered in outpatient departments for tuberculosis and lung diseases in group VI N (neoplastic) during the first half of 1995].
    Radzikowska E; Piasecki Z; Roszkowski K
    Pneumonol Alergol Pol; 1998; 66(1-2):79-87. PubMed ID: 9658885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thai experience in lung cancer treatment.
    Limsila T
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):646-50. PubMed ID: 3012791
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.